Sixteen new isothiazoloisoxazole 1,1-dioxides, one new isothiazolotriazole and one new isothiazolopyrazole have been synthesised by using 1,3-dipolar cycloadditions to isothiazole 1,1-dioxides. One sub-set of these isothiazoloisoxazoles showed low μM activity against a human breast carcinoma cell line, whilst a second sub-set plus the isothiazolotriazole demonstrated an interesting restricted rotation of sterically hindered bridgehead substituents. A thiazete 1,1-dioxide produced from one of the isothiazole 1,1-dioxides underwent conversion into an unknown 1,2,3-oxathiazolin-2-oxide upon treatment with Lewis acids, but was inert towards 1,3-dipoles and cyclopropenones. Six supporting crystal structures are included.
Introduction
Four-membered heterocyclic rings containing one nitrogen atom are well known within organic chemistry. The field is dominated by the β-lactams (1) [ Figure 1 ] due to the importance that they have acquired as anti-infective agents. [1] [2] [3] The corresponding β-sultams (2) are also known and have attracted attention as taurine precursors, 4,5 β-lactamase inhibitors, 6 D,D-peptidase inhibitors, 7 human neutrophil elastase inhibitors, [8] [9] [10] azoreductase inhibitors, 11 anti-inflammatory agents, 12 potential treatments for alcohol dependency, 13 SPase I inhibitors 14 and ClpP protease inhibitors, 15 and have attracted other mechanistic 16, 17 and synthetic efforts. [18] [19] [20] β-Sultam chemistry been a focus of our research for some time. [6] [7] [8] [9] [10] 12, 13, 17 
Figure 1. Heterocycles of interest in this work
Our interest in four-membered ring nitrogen heterocycles has also included the study of the chemistry of the unsaturated 1azetine (3), [21] [22] [23] [24] a system that is easily accessed from β-lactams, although the 1-azetine remains a heterocycle that attracts very little attention. 25 Nonetheless, we have shown that 1-azetines are able to act as precursors for the synthesis of benzoisoquinolines, 21 homotropane related heterocycles 22 and pyridines 23 via a formal [3+2]-cycloaddition reaction with cyclopropenones (which act as all-carbon 1,3-dipole equivalents) as well as acting as dipolarophiles for the synthesis of 1,2,4-oxadiazoles 24 via reaction with nitrile oxides. As a result of these successes, and given our interest in the β-sultam nucleus, we wished to explore the chemistry of the unsaturated β-sultam system, the thiazete 1,1-dioxide (4) . In parallel with our studies on the 1-azetine heterocycle, we anticipated that the thiazete 1,1-dioxide nucleus would be a suitable precursor for cyclopropenone based [3+2]-cycloaddition processes and 1,3dipolar cycloadditions, thus providing access to novel bicyclic β-sultams. We were particularly attracted to the thiazete 1,1dioxide (5a) that was produced by Clerici and co-workers 26 via ring contraction of an isothiazole 1,1-dioxide (6a) and by the under-explored and appealing nature of the chemistry that leads to this 4-membered unsaturated heterocycle.
Results and discussion

Synthesis and Reactivity of Isothiazole 1,1-dioxides and Thiazete 1,1-dioxides
We synthesised the thiazete 1,1-dioxide (5a) 26 from the precursor isothiazole 1,1-dioxide (6a) by adapting the route described by Clerici 27 as shown in Scheme 1. Thus, dibromination of an enone precursor gave a mixture of dibromo compounds (7a, Ar = 4-MeOC 6 H 4 ) which was reacted with Treatment of compound (8a) with methanesulfonyl azide initiates a reaction 27 whereupon the alkene undergoes a 1,3dipolar cycloaddition followed by loss of phenyldiazomethane to give an 82% yield of the pure N-methanesulfonylamidine (9a, Ar = 4-MeOC 6 H 4 , R = Et). Cyclisation of compound (9a) with t-butoxide in THF gave the alcohol (10a, Ar = 4-MeOC 6 H 4 , R = Et, 89%). The alcohol was converted into the corresponding tertiary chloride (11a) which formed in 95% yield together with 4% of the dichloro compound (12a). Elimination of HCl from compound (11a) gave an 86% yield of the isothiazole 1,1-dioxide (13a, Ar = 4-MeOC 6 H 4 , R = Et), whilst elimination of HCl from the dichloro compound 12a gave the 5-chloroisothiazole 1,1-dioxide (14a). The isothiazole 1,1-dioxide (13a) was converted (93% yield) into the 5bromoisothiazole 1,1-dioxide (15a) and thence to the 5methanesulfonylisothiazole 1,1-dioxide (6a, Ar = 4-MeOC 6 H 4 , R = Et) via the 5-methanesulfanyl 26, 28 and sulfoxide intermediates (16a) and (17a), in 97% and 67% yields, respectively. We were able to convert the chloro compound (14a) into the methanesulfanyl derivative (16a) but never reached the 97% yield achieved with the bromo derivative (15a). Direct oxidation of compound (16a) into (6a) was also found to be convenient, albeit in a reduced single step yield of 51%. When 5-methanesulfonyl-isothiazole 1,1-dioxide (6a) was treated with sodium azide in acetonitrile it underwent the expected 26 but remarkable ring contraction (see later for a mechanistic discussion) to furnish the desired thiazete 1,1dioxide (5a, Ar = Ar = 4-MeOC 6 H 4 , R = Et). We attempted the reaction of the thiazete 1,1-dioxide (5a) with nitrile oxides and cyclopropenones (19) in order to form cycloadducts (18) and (20) , illustrated in Scheme 1. No reactions of the imine present in the thiazete 1,1-dioxide (5a) were observed, and the starting material was returned unchanged in all cases, a huge disappointment given that we had shown that the imine within the 1-azetine system reacts easily with both nitrile oxides and cyclopropenones. [21] [22] [23] [24] Other 1,3-dipoles (nitrile ylides, nitrilimines, nitrones, aryl azides and azomethine ylides) and dienes were found to be similarly unreactive. Interestingly, when the cyclopropenone reaction was attempted in the presence of a Lewis acid, a reaction was observed. On these occasions, the product was found to be the previously unreported 1,2,3-oxathiazolin-2-oxide (21see Scheme 1), the product of a hitherto unknown rearrangement of the thiazete 1,1-dioxide (5) . This product was also obtained in the absence of the cyclopropenone. Compound (21) was typically formed as a ~2.5:1 mixture of diastereoisomers with the major diastereoisomer isolated in a maximum yield of 31% yield using zinc chloride as the Lewis acid, and for which we were unable to determine the relative stereochemistry. A possible mechanism for the formation of compound (21) from (5) is shown in Scheme 2, based upon a known rearrangement of simple (saturated) 3-aryl β-sultams into simple (saturated) 1,2,3-oxathiazolidines. 29 Scheme 2. Mechanism for formation of 1,2,3-oxathiazolin-2-oxide (21) Disappointed by the inert nature of thiazete 1,1-dioxide (5a) towards 1,3-dipoles and cyclopropenones, we next investigated the reactivity of isothiazole 1,1-dioxides (10a -17a) and (6a, Ar = 4-MeOC 6 H 4 , R = Et). No reactivity was observed from any of these compounds towards cyclopropenones. Compounds (10a -12a) were also unreactive towards 1,3-dipoles. However, compounds (13a -15a), (17a) and (6a) [Ar = 4-MeOC 6 H 4 , R = Et] were reactive towards a series of five nitrile oxides, forming a series of isothiazoloisoxazoles (22) as shown in Scheme 3 and Table 1 (entries ai). It is of note that we found the thioether compound (16a) (entry j, Table 1 ) to be unreactive, possibly due to the electron donating nature of this substituent when compared to the other isothiazole 1,1-dioxides used. The reactivity of compound (13a) towards nitrile oxides has also been investigated by Clerici (see below). 30 It is of note that all of the reactions were regioselective and diastereoselective, giving the syn-diastereoisomer shown in Scheme 3. The observed regiochemistry is predictable on the basis of the alkene polarity and was apparent from HMBC spectra. The syn-diastereoselectivity is explained by the concerted nature of the cycloaddition. The stereochemistry was apparent from NOESY spectra and other NMR studies (see below). We were also able to confirm the structures of compounds (22a), (22h) [both diastereoisomers] and (22i) by X-ray crystallographic studies. 31 We next decided to extend the scope of this reaction and produced a range of five additional isothiazole 1,1-dioxides (13b -f) (as shown in Table 2 ), four of which (13b, c, d and f) are previously unreported and were produced using the route described in Scheme 1 in the yields shown in Table 2 . In general, the chemistry proceeded without incident. However, all attempts to obtain pure samples of intermediate (8b -f) were unsuccessful. Fortunately, we found that the crude mixtures could be treated with methanesulfonyl azide whereupon the pure N-methanesulfonylamidines (9b -f) could be isolated in reasonable yields (see Table 2 ). There is great interest in azide to alkene 1,3-dipolar cycloaddition chemistry, 32-37 so we were particularly pleased to see that the key 1,3-dipolar cycloaddition/1,3-dipolar cycloreversion based conversion of compounds (8b -f) into (9b -f) showed itself to be repeatable and reliable even with crude starting material. Conversion of compounds (9b -f) into heterocycles (13b -f, see Table 2 for Ar and R) proceeded without further issues. Isothiazole 1,1dioxides (13b -f) were reacted with nitrile oxides to give the isothiazoloisoxazoles (22kt), again as single regio-and syndiastereoisomers, as shown in Table 1 . It is important to note that Clerici and co-workers have reported the synthesis of a library of six isothiazoloisoxazoles accessed from one of these isothiazole 1,1-dioxides (13a, Ar = 4-MeOC 6 H 4 , R = Et) 30 and six nitrile oxides as well as two further adducts isolated from the reactions of 3-benzylaminoisothiazole 1,1-dioxide 38 (not studied in our work). However, only 3 of the 19 compounds reported in Table 1 (compounds 22a, 22d and 22e) have been reported previously, and our work has demonstrated that this chemistry is more widely applicable than reported previously, both in terms of precursor (13) synthesis and adducts (22) produced. Scheme 3. Synthesis of isothiazoloisoxazoles (22) [see Table 1 ] Given that compound (6a) underwent the ring contraction to give thiazete (5a) upon treatment with sodium azide, we also explored the reactivity of compounds (14a -17a, Ar = 4-MeOC 6 H 4 , R = Et) towards sodium azide. Only compound (17a) showed a reaction and in this case we were able to isolate the previously unreported isothiazolotriazole cycloadducts (23a and b) [Scheme 4] as a ~5:6 mixture of diastereoisomers in a combined yield of 49% [we confirmed the structure of the major diastereoisomer by X-ray crystallography 31 ]. Clerici and co-workers also isolated an isothiazolotriazole when exploring the reactivity of isothiazole 1,1-dioxide (13a, Ar = 4-MeOC 6 H 4 , R = Et) towards sodium azide. 39 Together, these observations suggest that the ring contraction mechanism for the addition of sodium azide to isothiazole 1,1-dioxide (6a) to give the thiazete 1,1-dioxide (5a) may proceed via an isothiazolotriazole intermediate (as shown in Scheme 4) which, in the case of the sulfone, collapses to give the ring-contracted final product due to enhanced stability of the sulfone leaving group versus the sulfoxide leaving group. Finally, also shown in Scheme 4, we reacted the isothiazole 1,1-dioxide (13a) with a nitrilimine to give adduct (24, Ar = 4-MeOC 6 H 4 , R = Et) in 41% yield, a structure that we confirmed by X-ray crystallographic studies. 31 Attempted reaction with other nitrilium betaines (nitrile ylides and nitrile sulfides) was not fruitful, although adducts of isothiazole 1,1-dioxide (13a) with Münchnones, diazo compounds and aryl azides have been reported. [40] [41] [42] Scheme 4. Synthesis of azide and nitrilimine adducts (23) and (24) 
Conformational Studies of Isothiazoloisoxazoles
The NMR spectra of the previously unreported cycloadducts (22f -i, Figure 2 ) revealed some unexpected results. For compounds (22f) and (22g), the two pairs of aromatic protons on the bridgehead aryl group were expected to give two doublets in the 1 H NMR spectra integrating to two protons each. Instead, these protons appeared as two broad signals in a 1:3 ratio, indicating that they are in different electronic environments due, we assume, to a restricted rotation of the aromatic ring on the ring junction. For compound (22h), formed as a separable mixture of diastereoisomers, the aromatic protons of the bridgehead aryl group appeared as four distinct (albeit overlapping) signals which were broad for one isomer but resolved for the other. For compound (22i) the broadening of the signals in the 1 H NMR spectrum disappeared and the four aromatic protons of the bridgehead aryl group gave four very distinctive doublets of doublets. These results also indicate a restricted rotation of the aromatic ring and a different electronic environment for each proton.
In the 13 C NMR spectra for compounds (22f) and (22g), two flattened but distinct peaks appeared for the two aromatic CH carbons closer to the stereogenic centre at the ring junction, whereas no discrimination was observed between the two other aromatic CH carbons, i.e. those ortho to the methoxy group on the bridgehead aryl group. For the two diastereoisomers of compound (22h) and for compound (22i), the four aromatic CH carbons on the ring junction aryl group appeared as separate signals. These observations again indicate that the aromatic CH carbons on the ring junction aryl ring are in different environments, providing further evidence of the restriction of the rotation of the aromatic ring. Steric hindrance between the bridgehead aryl group and the substituent Y across a syn-ring junction as shown in Figure 2 would account for the restricted rotation of the aromatic ring. The broadening of the signals for the aromatic protons in the 1 H NMR spectra decreases in the order Cl < Br < SOMe < SO 2 Me. The larger the substituent, the smaller the amplitude of the rotation, which then allows a more defined electronic environment, 43 and a more resolved signal. This phenomenon also accounts for the intact AB system that is observed in those examples of adducts (22) where Y = H in which there is free rotation of the aromatic ring at the ring junction due to minimal steric hindrance. In these cases, the two aromatic protons in each proton pair are in the same environment and appear as the expected two doublets.
In the 13 C NMR spectra of compounds (22f) and (22g), efficient relaxation and environmental exchange accounts for the observed flattening, broadening and coalescence of some signals. 43 For compounds (22h) and (22i), the presence of four aromatic CH carbon signals for the bridgehead aryl group is due to the increasingly restricted rotation of the aromatic ring at the ring junction. In those systems with Y = H, rotation is not restricted and only two CH environments are observed for the bridgehead aryl group.
Compounds (23a/b)with only one aryl ringexhibited the same phenomena, with the presence of four CH signals in the aromatic region of the 13 C NMR spectrum for each diastereoisomer and the presence of four non-equivalent aromatic protons (with some overlap) in the 1 H NMR spectra.
Antiproliferative Activity of Isothiazoloisoxazoles
Whilst the biological activity of monocyclic isothiazole dioxides as protein farnesyltransferase inhibitors 44, 45 and antiproliferatives 45, 46 has been established, we are aware of no reports dealing with bicyclic systems. Thus, we investigated the activity of a subset of the isothiazoloisoxazoles as antiproliferative agents. Compounds (22k), (22m), (22o) and (22p) had suitable solubility in DMSO and were tested for cytotoxicity against human breast carcinoma cell line, MCF-7 cells. IC 50 values are shown in Table 3 . Compound (22o) only showed inhibition of cell growth after 96 hours of incubation whereas compounds (22k), (22m) and (22p) showed inhibition at 48 and 72 hours. Compound (22m) showed the greatest activity, and work is currently underway in our laboratories to discover derivatives with nM levels of activity. and 6a, 26 8a, 8e, 9a, 9e, 10a, 10e, 11a, 11e, 13a and 13e, 27 15a, 47 16a, 28 and 22a, 22d and 22e 30 have been reported previously, although only compounds 5a, 6a and 15a had full spectroscopic characterisation data (including 13 , d and f, 10c, d and f, 11c, d and f,  13c, d and f, 22c and 22k -t are detailed in the Supporting Information.
2-(Alkylamino)-1-aryl-3-phenyl-prop-2-en-1-ones (8b -8d, 8f)
To the 2,3-dibromo-1-aryl-3-phenyl-propan-1-one (7) (4.5 -5.0 g, 11.4 -12.6 mmol) stirring in ethanol (10 -40 mL) at room temperature under an atmosphere of nitrogen was added the amine (2 equivalents, 22.8 -25.2 mmol) and the mixture allowed to stir for 24 hours. After this time sodium ethoxide (1 equivalent, 11.4 -12.6 mmol) was added and the reaction mixture was stirred for a further 24 hours. Solvents were then removed under reduced pressure and the residues were dissolved in dichloromethane. The solution was filtered to remove sodium bromide and the filtrate was concentrated under reduced pressure. The crude products were taken to the next stage without further purification or analysis.
2-(4-Methoxyphenyl)-N'-methylsulfonyl-2-oxo-N,Ndipropyl-acetamidine (9b)
Under an atmosphere of nitrogen, a solution of the 2-(dipropylamino)-1-(4-methoxyphenyl)-3-phenyl-prop-2-en-1one (8b) crude reaction mass (12.56 mmol based upon 7a, 5.0 g) in ethanol (45 mL) was added to a solution of methanesulfonyl azide (1.79 g, 14.80 mmol) in ethanol (15 mL). The reaction mixture was set to stir at reflux for 24 hours. After this time, solvents were removed under reduced pressure. The crude product was purified by gravity silica column chromatography with a 1:1 petroleum ether:ethyl acetate solvent system to yield the pure product as an orange oil (3.40 g, 80%). 
3-(Dipropylamino)-4-(4-methoxyphenyl)-1,1-dioxo-5Hisothiazol-4-ol (10b)
To 2-(4-methoxyphenyl)-N'-methylsulfonyl-2-oxo-N,Ndipropyl-acetamidine (9b) (3.40 g, 9. 98 mmol) in dry tetrahydrofuran (12 mL) under an atmosphere of nitrogen, a 20% w/v solution of potassium t-butoxide in tetrahydrofuran (6.00 mL, 9.98 mmol) was added rapidly at room temperature and the reaction mixture set to stir for 24 hours. After this time, the reaction mixture was neutralised with 1M hydrochloric acid. The aqueous mixture was extracted with dichloromethane (3 × 25 mL) and the organic layers combined and washed with water. The organics were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to yield the product as a yellow oil (3.35 g, 99%) which was used directly in the next step. 
4-Chloro-4-(4-methoxyphenyl)-1,1-dioxo-N,N-dipropyl-5Hisothiazol-3-amine (11b)
Under an atmosphere of nitrogen, thionyl chloride (6.38 mL, 87.90 mmol) was added to 3-(dipropylamino)-4-(4methoxyphenyl)-1,1-dioxo-5H-isothiazol-4-ol (10b) (1.00 g, 2.93 mmol) and the mixture set to stir at reflux for 24 hours. After this time the excess thionyl chloride was removed under reduced pressure. The residues were then dissolved in dichloromethane and neutralised with 10% w/v aqueous sodium bicarbonate solution. The aqueous layer was removed and extracted with dichloromethane (3 × 25 mL) and the organic layers combined and washed with water. The organics were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by gravity silica column chromatography (2:1 PE:EtOAc) to yield the pure product as a yellow oil (1.06 g, 97%). 
4-(4-Methoxyphenyl)-1,1-dioxo-N,N-dipropyl-isothiazol-3-amine (13b)
To 4-chloro-4-(4-methoxyphenyl)-1,1-dioxo-N,N-dipropyl-5Hisothiazol-3-amine (11b) (3.72 g, 10.34 mmol) in dry acetone (50 mL) under an atmosphere of nitrogen, anhydrous potassium carbonate (1.57 g, 11.37 mmol) was added and the reaction mixture set to stir at reflux for 24 hours. After this time the mixture was filtered to remove excess potassium carbonate and the solvents removed under reduced pressure. The residues were dissolved in dichloromethane and neutralised with 1M aqueous hydrochloric acid. The aqueous layer was removed and extracted with dichloromethane (3 × 25 mL) and the organic layers combined and washed with water. The organics were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to yield the product as a brown oil (3.30 g, 76%) which was a single spot by TLC and did not need to be purified further. 
5-Chloro-3-diethylamino-4-(4-methoxyphenyl)isothiazol-1,1dioxide (14a)
A mixture of 4-chloroisothiazol-1,1-dioxide (11a) and 4,5dichloroisothiazolin-1,1-dioxide (12a) (3.23 g, ~10/1 mixture estimated by NMR) [see Supporting Information] was dissolved in dry acetone (10 mL) and potassium carbonate (1.35 g, 9. 77 mmol) was added in one portion. The mixture was heated at reflux temperature under nitrogen for 8 days. The solvent was removed in vacuo and the residue was dissolved in DCM (15 mL) and neutralised with a 10% aqueous solution of hydrochloric acid. The aqueous layer was extracted with DCM (2 × 10 mL) and the combined organics layer were washed with water (2 × 10 mL), dried over Na 2 SO 4 and filtered. The solvent was evaporated under reduced pressure to give the crude product as a sticky orange solid (2.21 g). Purification by gravity silica chromatography (PE/EtOAc: 2/1) afforded the isothiazol-1,1-dioxide (13a) (1.24 g, data as per Supporting Information) and the 5-chloroisothiazol-1,1-dioxide (14a) as a yellow solid (0.22 g, m.p. = 123 -125 °C). Data for (14a): 
3-Diethylamino-5-methanesulfinyl-4-(4methoxyphenyl)isothiazol-1,1-dioxide (17a)
3-Diethylamino-5-methanesulfanyl-4-(4-methoxyphenyl)isothiazol-1,1-dioxide (16a) (500 mg, 1.47 mmol) [see Supporting Information], was dissolved in dry DCM (10 mL) and m-CPBA (253 mg, 1.47 mmol) was added in one portion. The reaction was stirred at room temperature under nitrogen and monitored by thin layer chromatography. Further portions of m-CPBA were added to the mixture to complete the reaction (after 6 hours: 51 mg, 0.30 mmol; after 27 hours: 25 mg, 0.14 mmol; after 50 hours: 25 mg, 0.14 mmol). After 54 hours, the m-chlorobenzoic acid precipitate was filtered off, and the filtrate was washed sequentially with a 20% aqueous NaHCO 3 solution (5 mL) and water (2 × 5 mL). The organic layer was separated, dried over anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure to give the crude product as a yellow solid which was purified by gravity silica chromatography (PE/ethyl acetate: gradient elution 2/1, 3/2, 1/1) to yield the product as a yellow solid (350 mg, 67%, m.p. = 167 -169 °C). 
1,2,3-Oxathiazolin-2-oxide (21)
3-Diethylamino-1,2-thiazetin-1,1-dioxide (5a) (80 mg, 0.26 mmol) and zinc chloride (260 μL of a 1M solution in diethyl ether, 0.26 mmol) were dissolved in toluene (2 mL). The whole was stirred under nitrogen and heated at reflux for a further 48 hours. The solvent was removed in vacuo to give the crude product as a dark brown oil which was purified by gravity silica chromatography (hexane/EtOAc: 2/1) to give the product as a pure diastereoisomeric fraction (25 mg, 31 %) together with a second fraction as a mixture of diastereoisomers (10 mg, 13 %).
Pure diastereoisomer: 
3-Diethylamino-3a-(4-methoxyphenyl)-6-phenylisothiazolino-[4,5-d]isoxazolin-1,1-dioxide (22b)
3-Diethylamino-4-(4-methoxyphenyl)-isothiazol-1,1-dioxide (13a) (100 mg; 0.34 mmol) and benzohydroximoyl chloride (53 mg; 0.34 mmol) were suspended in dry diethyl ether (5 mL). Triethylamine (47 µL; 34 mg; 0.34 mmol) in dry diethyl ether (10 mL) was added drop-wise to the mixture over 5 -6 hours. The mixture was stirred overnight (20 hours) under nitrogen, filtered, and the solvent evaporated under reduced pressure to give the crude product as a pale yellow solid (170 mg). It was purified by gravity silica chromatography (PE/EtOAc: 2/1) to give the product as a white fluffy solid (99 mg; 71%; m.p. = 78 -80 °C). 
6a-Chloro-3-diethylamino-3a,6-di(4-methoxyphenyl)isothiazolino[4,5-d]isoxazolin-1,1-dioxide (22f)
Using the procedure above for compound (22b), 5-chloro-3diethylamino-4-(4-methoxyphenyl)-isothiazol-1,1-dioxide (14a) (27 mg; 0.08 mmol), 4-methoxybenzohydroximoyl chloride (15 mg; 0.08 mmol) and triethylamine (12 μL; 8.7 mg; 0.09 mmol) gave the crude product as a white oily solid (85 mg). Purification by gravity silica chromatography (PE/EtOAc: 3/1) afforded the product as a yellow oil (22 mg; 56%). 
6a-Bromo-3-diethylamino-3a,6-di(4-methoxyphenyl)isothiazolino[4,5-d]isoxazolin-1,1-dioxide (22g)
Using the procedure above for compound (22b), 5-bromo-3diethylamino-4-(4-methoxyphenyl)-isothiazol-1,1-dioxide (15a) (102 mg; 0.27 mmol), 4-methoxybenzohydroximoyl chloride (51 mg; 0.27 mmol) and triethylamine (38 μL; 27 mg; 0.27 mmol) gave a crude product which was purified by gravity silica chromatography (PE/EtOAc: 3/1) to give the product as an orange oil (77 mg; 54%). 
3-Diethylamino-6a-methanesulfinyl-3a,6-di(4-methoxyphenyl)isothiazolino[4,5-d]isoxazolin-1,1-dioxide (22h)
Using the procedure above for compound (22b), 3diethylamino-5-methanesulfinyl-4-(4-methoxyphenyl)isothiazol-1,1-dioxide (17a) (100 mg; 0.28 mmol), 4methoxybenzohydroximoyl chloride (52 mg; 0.28 mmol) and triethylamine (39 μL; 28 mg; 0.28 mmol) gave the crude product as a yellow oil (141 mg). Purification by gravity silica chromatography (hexane/EtOAc: 2/1) afforded the two diastereoisomers, one as a yellow solid (48 mg; 34%; m.p. = 192 -193 °C) and the other as a yellow solid (26 mg, 18%; m.p. 207 -209 °C) in a ~2:1 ratio. 
